Kenya is set to begin MPOX vaccinations in December, enhancing its defense against the virus, which has impacted multiple African countries. The Ministry of Health’s Department for Public Health and Professional Standards has confirmed that vaccine doses are expected to arrive soon, with the country actively securing supplies through the Africa Centres for Disease Control and Prevention (Africa CDC) and independent procurement.
Currently, MPOX vaccinations have already been initiated by the Africa CDC in three African nations: the Democratic Republic of Congo, Rwanda, and Nigeria. Due to high demand and the costs associated with the MPOX vaccine, only 5.6 million doses are presently available across the continent. The Africa CDC, in collaboration with global health organizations like the World Health Organization (WHO), GAVI, and UNICEF, is working to improve vaccine access in the region.
Kenya’s proactive approach to combating MPOX has received positive recognition. Public Health Principal Secretary Mary Muthoni has been instrumental in coordinating a multi-sectoral team to establish and implement strategies to counter the virus. Over the weekend, Muthoni chaired a meeting to assess current efforts and introduce additional measures. Speaking on Kenya’s progress, she noted the significance of the country’s preparedness in protecting its citizens and preventing the spread of the virus.
As part of its preventive strategy, Kenya has bolstered surveillance at its borders, screening over 1.5 million travelers by Friday. The screening initiative is intended to detect potential MPOX cases and reduce transmission risks from incoming travelers.
Dr. Matendechero, Deputy Director-General of Public Health, highlighted Kenya’s efforts as exemplary, describing them as a model for other nations. “Kenya’s progress serves as a benchmark for regional preparedness,” he said.
Africa CDC data indicates there have been approximately 9,000 confirmed MPOX cases out of an estimated 45,000 suspected cases across the continent.
